Otolaryngology Doctors in Aurora, CO Accepting Medicare

45 Otolaryngology doctors found. Showing 41 - 45

Dr. Nicole Lynn Wershoven, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 13001 E 17th Pl, Aurora, CO 80045 Phone: 303-724-4585

Bruce Jafek, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Dr. Daniel Steven Fink, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Conner Massey, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Medicare Enrolled Practice Location: 13001 E 17th Ave, University Of Colorado School Of Medicine Gme, Aurora, CO 80045 Phone: 303-724-1957

Ross Shockley, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

News Archive

RXi Pharmaceuticals, TransDerm collaborate on study of RXi's proprietary compounds in dermatology applications

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.

Scientific revelations discovered during Retina Implant's first human clinical trial

Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company's first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company's expectations for their first trial.

Scientists engineer first drug-delivery particles capable of passing through human mucus

Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.

Half the drugs in use damage gut bacteria, says new study

A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3(current)